ArticleTheranostics2019

Transcriptional Downregulation of miR-4306 serves as a New Therapeutic Target for Triple Negative Breast Cancer.

Zitong Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.